Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

June 01, 1998; Volume 26,Issue 6

Articles

  • You have access
    Glucuronidation of Amines and Other Xenobiotics Catalyzed by Expressed Human UDP-Glucuronosyltransferase 1A3
    Mitchell D. Green, Christopher D. King, Behnaz Mojarrabi, Peter I. Mackenzie and Thomas R. Tephly
    Drug Metabolism and Disposition June 1998, 26 (6) 507-512;
  • You have access
    The In Vitro Metabolism of Penclomedine in Mouse, Rat, and Human Systems
    Neil R. Hartman, K. U. Leo, T. G. Brewer and J. M. Strong
    Drug Metabolism and Disposition June 1998, 26 (6) 513-519;
  • You have access
    In Vitro and In Vivo Evaluations of Intestinal Barriers for the Zwitterion L-767,679 and Its Carboxyl Ester Prodrug L-775,318
    Thomayant Prueksaritanont, Polly DeLuna, Lynn M. Gorham, Bennett Ma, Dosinda Cohn, Jianmei Pang, Xin Xu, Kwan Leung and Jiunn H. Lin
    Drug Metabolism and Disposition June 1998, 26 (6) 520-527;
  • You have access
    Biotransformation of Tolterodine, a New Muscarinic Receptor Antagonist, in Mice, Rats, and Dogs
    Stig H. G. Andersson, Anders Lindgren and Hans Postlind
    Drug Metabolism and Disposition June 1998, 26 (6) 528-535;
  • You have access
    In Vitro Characterization of Cytochrome P450 2D6 Inhibition by Classic Histamine H1 Receptor Antagonists
    Bettina A. Hamelin, Asmàa Bouayad, Benoît Drolet, Anne Gravel and Jacques Turgeon
    Drug Metabolism and Disposition June 1998, 26 (6) 536-539;
  • You have access
    Biotransformation of the Anthraquinones Emodin and Chrysophanol by Cytochrome P450 Enzymes
    Stefan O. Mueller, Helga Stopper and Wolfgang Dekant
    Drug Metabolism and Disposition June 1998, 26 (6) 540-546;
  • You have access
    Thiol Agents Separate Nitric Oxide Formation from Vasodilation Induced by Glyceryl Trinitrate
    Mark F. Kearney, James F. Brien, Gerald S. Marks, Hua Lei and Kanji Nakatsu
    Drug Metabolism and Disposition June 1998, 26 (6) 547-551;
  • You have access
    Metabolism of the Human Immunodeficiency Virus Protease Inhibitors Indinavir and Ritonavir by Human Intestinal Microsomes and Expressed Cytochrome P4503A4/3A5: Mechanism-Based Inactivation of Cytochrome P4503A by Ritonavir
    Tatiana Koudriakova, Eugenia Iatsimirskaia, Ilya Utkin, Eric Gangl, Paul Vouros, Elena Storozhuk, Daniela Orza, Julia Marinina and Nicholas Gerber
    Drug Metabolism and Disposition June 1998, 26 (6) 552-561;
  • You have access
    Analysis of Metabolite Formation Pharmacokinetics after Intravenous and Oral Administration of the Parent Drug Using Inverse Laplace Transformation
    Michael Weiss
    Drug Metabolism and Disposition June 1998, 26 (6) 562-565;
  • You have access
    N-Dealkylation and Hydroxylation of Ebastine by Human Liver Cytochrome P450
    Takanori Hashizume, Masashi Mise, Yoshiaki Terauchi, Luan O, Toshihiko Fujii, Hisashi Miyazaki and Tadanobu Inaba
    Drug Metabolism and Disposition June 1998, 26 (6) 566-571;
  • You have access
    Trazodone Is Metabolized tom-Chlorophenylpiperazine by CYP3A4 from Human Sources
    Susan Rotzinger, Jian Fang and Glen B. Baker
    Drug Metabolism and Disposition June 1998, 26 (6) 572-575;
  • You have access
    Pharmacokinetics of Meloxicam in Animals and The Relevance to Humans
    Ulrich Busch, Jochen Schmid, Günther Heinzel, Helmut Schmaus, Jürgen Baierl, Claudia Huber and Willy Roth
    Drug Metabolism and Disposition June 1998, 26 (6) 576-584;
  • You have access
    Physiologically Based Pharmacokinetics Model of Primidone and Its Metabolites Phenobarbital and Phenylethylmalonamide in Humans, Rats, and Mice
    Hisham A. El-Masri and Christopher J. Portier
    Drug Metabolism and Disposition June 1998, 26 (6) 585-594;
  • You have access
    Effect of Hypoalbuminemia on the Disposition of Theophylline
    Hironori Nakura, Tomonori Tateishi, Minoru Watanabe, Masako Asoh, Masami Tanaka, Toshio Kumai and Shinichi Kobayashi
    Drug Metabolism and Disposition June 1998, 26 (6) 595-597;
  • You have access
    Tissue-Specific Expression of Rat Sulfotransferase Messenger RNAs
    Robert T. Dunn and Curtis D. Klaassen
    Drug Metabolism and Disposition June 1998, 26 (6) 598-604;

Short Communication

  • You have access
    Human Halothane Reduction In Vitro by Cytochrome P450 2A6 and 3A4: Identification of Low and HighKM Isoforms
    Douglas K. Spracklin and Evan D. Kharasch
    Drug Metabolism and Disposition June 1998, 26 (6) 605-607;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 26, Issue 6
1 Jun 1998
  • Table of Contents
  • Index by author
Sign up for alerts

Jump to

  • Articles
  • Short Communication
  • Most Read
Loading
  • Metabolism and Disposition of Volanesorsen across Species
  • Tissue Drug Concentrations: Beyond the Free Drug Hypothesis
  • PBPK Modeling for Clopidogrel and Its Active Metabolite
  • Pharmacokinetics and Disposition of Biologics
  • Physiology of the Neonatal Gastrointestinal System
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics